Keyphrases
Chemotherapy
100%
B-cell Lymphoma 2 (Bcl-2)
100%
B-cell Lymphoma
100%
BCL6
100%
Follicular Lymphoma
100%
Triple Hit
100%
Stem Cell Transplantation
75%
Diffuse Large B-cell Lymphoma (DLBCL)
75%
Response to Chemotherapy
50%
Tumor
25%
Poor Prognosis
25%
Lymphoma
25%
Aggressive Tumor
25%
Remission
25%
Burkitt Lymphoma
25%
Complete Remission
25%
Clinical Follow-up
25%
As(V)
25%
Tumor-associated
25%
Interferon Regulatory Factor 4 (IRF4)
25%
Complete Response
25%
Partial Response
25%
MYC Expression
25%
CD20
25%
World Health Organization Classification
25%
Follow-up Time
25%
No Response
25%
Proliferation Rate
25%
Immunochemotherapy
25%
Germinal Center B Cells
25%
T-cell Antigen
25%
High Proliferation Index
25%
CD10
25%
Epstein-Barr Virus-encoded RNA
25%
Clinicopathologic Findings
25%
FOXP1
25%
MUM1
25%
Unclassifiable B-cell Lymphoma
25%
Triple-hit Lymphoma
25%
Medicine and Dentistry
Chemotherapy
100%
B-Cell Lymphoma
100%
Follicular Lymphoma
66%
Diffuse Large B-Cell Lymphoma
50%
Stem Cell Transplant
50%
Neoplasm
33%
CD20
16%
Germinal Center
16%
B Cell
16%
Epstein Barr Virus
16%
Burkitt's Lymphoma
16%
T Lymphocyte Antigen
16%
Interferon Regulatory Factor 4
16%